Viewing Study NCT02327169


Ignite Creation Date: 2025-12-24 @ 11:00 PM
Ignite Modification Date: 2026-02-26 @ 2:15 AM
Study NCT ID: NCT02327169
Status: COMPLETED
Last Update Posted: 2020-02-25
First Post: 2014-12-23
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic Malignancies
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Nonhematologic Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Drug therapy View